Clinical Trials

1 enrolled

CNSDermatologic

Brain Neoplasms, Melanoma

NCT04741997 2026-03-02

Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma

50 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Melanoma

NCT07210632 2026-02-27

Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)

38 enrolled

CNS

Brain Neoplasms, Glioma

NCT05358938 2026-02-06

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

22 enrolled

Melanoma, Motor Activity, Skin Neoplasms, Carcinoma, Merkel Cell

NCT03543969 2026-02-05

Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma

14 enrolled

Melanoma, Skin Neoplasms

NCT07328087 2026-01-09

COLONYVAQ™-CRC

12 enrolled

Colorectal Neoplasms

NCT02210117 2026-01-07

Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery

104 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT02652455 2025-08-19

Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma

11 enrolled

Melanoma, Skin Neoplasms

NCT03463408 2025-08-11

Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma

14 enrolled

Sarcoma

NCT04581382 2025-07-10

Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma

18 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Melanoma

NCT07017816 2025-06-17

JACOB

18 enrolled

CNS

Neoplasms, Germ Cell and Embryonal, Pinealoma, Central Nervous System Neoplasms

NCT03143270 2025-05-02

A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer

20 enrolled

Liver Neoplasms

NCT03162731 2025-04-29

Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage III-IVB Head and Neck Cancer

24 enrolled

Head & Neck

Lymphoid Interstitial Pneumonia, Laryngeal Diseases

NCT04134325 2025-04-16

Study of PD-1 Inhibitors After CD30.CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma

10 enrolled

Lymphoid

Hodgkin Disease

NCT03311958 2025-04-06

Molecular Monitoring With Circulating Tumor DNA and Nivolumab Maintenance

15 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT05498792 2025-04-04

Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma

12 enrolled

Melanoma

NCT05188118 2024-11-06

Rapid Sequencing of Approved Therapies in Patients with Metastatic or Unresectable Clear Cell Renal Cell Carcinoma

20 enrolled

Genitourinary

Carcinoma, Renal Cell, Neoplasm Metastasis

NCT05482451 2024-08-21

Nivolumab and All-trans Retinoic Acid for Pancreatic Cancer

10 enrolled

Pancreatic Neoplasms

NCT03970252 2024-08-09

Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer

28 enrolled

Borderline Resectable Pancreatic Adenocarcinoma

NCT03316274 2024-06-25

Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma

12 enrolled

Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

NCT03519308 2024-03-15

A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer

3 enrolled 13 charts

Pancreatic Neoplasms

NCT03812562 2024-02-21

Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical Resection

2 enrolled

Phase EARLY_PHASE1 Unknown

Carcinoma, Hepatocellular

NCT06204614 2024-01-12

Drug Screening Using IMD in Bladder Cancer

18 enrolled

Genitourinary

Muscle Invasive Bladder Urothelial Carcinoma

NCT03575598 2023-07-27

SNOW

10 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT03526185 2022-07-25

A Pilot Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes

6 enrolled

Phase EARLY_PHASE1 Withdrawn

Melanoma

NCT04891718 2022-07-08

CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia

DermatologicHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymphoma, Melanoma, Sarcoma

NCT04272333 2022-04-14

Intratumoral Microdosing of Motolimod in HNSCC

Phase EARLY_PHASE1 Unknown

1 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT04570683 2020-09-30

Laser Immunotherapy With and Without Topical Anti-PD1 in Basal Cell Carcinomas

30 enrolled

Carcinoma, Basal Cell

NCT03224871 2020-04-07

UCDCC#269: A Pilot Study of Interlesional IL-2 and RT in Patients With NSCLC.